Russell Investments Group, Ltd.
Position in NBIX — Neurocrine Biosciences Inc
CIK 1692234
Seattle, WA
Position in NBIX
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$28,950,515
+$11,249,715 QoQ
Shares Held
219,755
+76.1% QoQ
Ownership
0.219%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 75.20101931696662.ToString("F0")%
Shared 0.ToString("F0")%
None 24.798980683033378.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Russell Investments Group, Ltd. holds $291,116,040 across 50 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (9.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
578,753 | $68,414,382 | |
| 2 | VTRS |
Viatris Inc
|
3,347,591 | $45,225,949 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
67,551 | $40,056,384 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
219,755 | $28,950,515 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
645,037 | $15,435,730 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
393,588 | $11,854,866 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
193,436 | $10,698,942 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
138,941 | $10,684,560 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $28,950,515 | 219,755 | Shares | Other | 2026-05-08 | |
| 2025-12-31 | $17,700,800 | 124,803 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $15,711,604 | 111,922 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $10,579,194 | 84,169 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $11,126,132 | 100,598 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $17,228,618 | 126,217 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $24,285,722 | 210,777 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $39,753,724 | 288,761 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $48,177,798 | 349,317 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $53,399,558 | 405,279 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $46,557,337 | 413,843 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $37,754,322 | 400,364 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $34,696,390 | 342,782 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $18,678,622 | 156,385 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $12,993,409 | 122,337 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $14,846,202 | 152,300 | Shares | Defined | 2022-07-29 | |
| 2022-03-31 | $13,170,561 | 140,486 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $4,332,682 | 50,871 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $3,282,325 | 34,223 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $2,126,829 | 21,854 | Shares | Defined | 2021-08-04 | |
| 2021-03-31 | $1,663,072 | 17,101 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $1,344,870 | 14,031 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $1,963,681 | 20,421 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $9,670,330 | 79,265 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $9,384,527 | 108,429 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||